J C Trinchet

Summary

Country: France

Publications

  1. doi request reprint [Hepatocellular carcinoma: increasing incidence and optimized management]
    J C Trinchet
    Service d Hepatogastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 33:830-9. 2009
  2. ncbi request reprint Hepatocellular carcinoma in 2014: Current situation and future prospects
    J C Trinchet
    Department of Hepato Gastroenterology, Jean Verdier Hospital, AP HP, Avenue du 14 Juillet, 93140 Bondy, France Paris Public Hospitals Health Service and Research and Training Unit SMBH Paris 13 University, Bobigny, France INSERM U674 UMR 1162, Paris, France Electronic address
    Diagn Interv Imaging 95:705-8. 2014
  3. ncbi request reprint [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue]
    Jean Claude Trinchet
    Assistance Publique Hopitaux de Paris, Hopital Jean Verdier, Service d Hepato Gastroenterologie, 93140 Bondy, France
    Rev Prat 63:222-5. 2013
  4. ncbi request reprint Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities
    Jean Claude Trinchet
    AP HP, Hopital Jean Verdier, Service d Hepato Gastroenterologie, Bondy, F 93140, France
    Hepatology 54:1987-97. 2011
  5. doi request reprint [Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma]
    J C Trinchet
    Service dd hépato gastro entérologie, Hopital Jean Verdier, APHP, Universite Paris XIII, 93143 Bondy Cedex, France
    Bull Cancer 96:35-43. 2009
  6. ncbi request reprint Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Jean Claude Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, 93143 Bondy Cedex, France
    World J Gastroenterol 13:2455-60. 2007
  7. ncbi request reprint [Sarcoidosis and the liver]
    N Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Bondy, Cedex
    Ann Med Interne (Paris) 152:103-7. 2001
  8. doi request reprint Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis
    P Nahon
    Service d Hepatogastroenterologie, Hopital Jean Verdier, AP HP, avenue du 14juillet, 93140 Bondy, France
    Gastroenterol Clin Biol 34:1-7. 2010
  9. ncbi request reprint Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    V Grando-Lemaire
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy, France
    J Hepatol 31:508-13. 1999
  10. doi request reprint HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
    G Nkontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    J Viral Hepat 18:e516-22. 2011

Collaborators

Detail Information

Publications55

  1. doi request reprint [Hepatocellular carcinoma: increasing incidence and optimized management]
    J C Trinchet
    Service d Hepatogastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 33:830-9. 2009
    ....
  2. ncbi request reprint Hepatocellular carcinoma in 2014: Current situation and future prospects
    J C Trinchet
    Department of Hepato Gastroenterology, Jean Verdier Hospital, AP HP, Avenue du 14 Juillet, 93140 Bondy, France Paris Public Hospitals Health Service and Research and Training Unit SMBH Paris 13 University, Bobigny, France INSERM U674 UMR 1162, Paris, France Electronic address
    Diagn Interv Imaging 95:705-8. 2014
    ..Assay of serum alpha-fetoprotein has no benefit. In developed countries, failure to identify patients with cirrhosis and inadequate adherence to guidelines greatly reduces the effectiveness of screening for HCC. ..
  3. ncbi request reprint [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue]
    Jean Claude Trinchet
    Assistance Publique Hopitaux de Paris, Hopital Jean Verdier, Service d Hepato Gastroenterologie, 93140 Bondy, France
    Rev Prat 63:222-5. 2013
    ....
  4. ncbi request reprint Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities
    Jean Claude Trinchet
    AP HP, Hopital Jean Verdier, Service d Hepato Gastroenterologie, Bondy, F 93140, France
    Hepatology 54:1987-97. 2011
    ..002). No difference in either HCC incidence (P = 0.13) or in prevalence of tumors ≤30 mm in diameter (79% versus 70%, P = 0.30) was observed between the randomized groups...
  5. doi request reprint [Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma]
    J C Trinchet
    Service dd hépato gastro entérologie, Hopital Jean Verdier, APHP, Universite Paris XIII, 93143 Bondy Cedex, France
    Bull Cancer 96:35-43. 2009
    ....
  6. ncbi request reprint Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Jean Claude Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, 93143 Bondy Cedex, France
    World J Gastroenterol 13:2455-60. 2007
    ..It is strongly suggested that antiviral treatment of HCV infection could prevent HCC occurrence, even in cirrhotic patients, mainly when a sustained virological response is obtained...
  7. ncbi request reprint [Sarcoidosis and the liver]
    N Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Bondy, Cedex
    Ann Med Interne (Paris) 152:103-7. 2001
    ..Corticosteroids are the main treatment, indicated in case of symptomatic liver involvement and/or in case of extensive liver fibrosis. When portal hypertension is developed, specific treatment of esophageal varices is required...
  8. doi request reprint Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis
    P Nahon
    Service d Hepatogastroenterologie, Hopital Jean Verdier, AP HP, avenue du 14juillet, 93140 Bondy, France
    Gastroenterol Clin Biol 34:1-7. 2010
    ....
  9. ncbi request reprint Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    V Grando-Lemaire
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy, France
    J Hepatol 31:508-13. 1999
    ..In these patients, epidemiological factors and the histopathology of the non-neoplastic liver are not well known. The aim of this study was to clarify these points...
  10. doi request reprint HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
    G Nkontchou
    Department of Hepatogastroenterology, Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris, Bondy, France
    J Viral Hepat 18:e516-22. 2011
    ..58 (1.80-7.13); P = 0.003]. For patients with HCV cirrhosis and ongoing infection, infection with genotype 3 is independently associated with an increased risk of HCC development...
  11. doi request reprint Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study
    A Mahmoudi
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP, UFR SMBH, Universite Paris 13, 93410 Bondy, France
    Clin Res Hepatol Gastroenterol 35:731-7. 2011
    ..Cirrhosis is considered as a risk factor for osteoporosis whose prevalence is poorly known. The aim was to assess prospectively bone mineral density (BMD) in patients with alcoholic or viral compensated cirrhosis...
  12. ncbi request reprint A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    S Chevret
    Departement de Biostatistique et Informatique Medicale, Hopital Saint Louis, Paris, France
    J Hepatol 31:133-41. 1999
    ..The aim of this prospective study was to provide a simple classification for predicting survival of patients with hepatocellular carcinoma, based on a multivariable Cox model...
  13. ncbi request reprint [Alcoholic liver cirrhosis. Screening for hepatocellular carcinoma in liver cirrhosis]
    J C Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Bondy
    Presse Med 30:1164-9. 2001
    ..Large-scale prospective studies will be completed in the upcoming years and are expected to provide evidence validating the principle of screening and early treatment...
  14. ncbi request reprint Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis
    M Ziol
    Department of Pathology, H pital Jean Verdier, Bondy, France
    J Hepatol 34:254-60. 2001
    ..The aim of this study was to quantify hepatocyte apoptosis in AH and to attempt to relate it to the clinical and biological severity of the disease...
  15. ncbi request reprint Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study
    N Ganne-Carrie
    Department of Hepato Gastroenterology, Hospital Jean Verdier, Bondy, 93140, France
    J Autoimmun 14:189-93. 2000
    ..This finding raises questions about the mechanism of autoimmunity induced by HCV and provides an explanation for the high rate of overt autoimmune thyroiditis during interferon treatment in these patients...
  16. ncbi request reprint Intra-arterial chemoembolization in patients with hepatocellular carcinoma
    J C Trinchet
    Service d Hepato Gastroenterologie, HUpital Jean Verdier, Universite Paris XIII, Bondy, France
    Hepatogastroenterology 45:1242-7. 1998
    ..Moreover, arterial embolization can be performed without chemotherapy, and the procedure should not be repeated in the short term...
  17. ncbi request reprint [The impact of large vessel proximity on effectiveness of radiofrequency ablation of hepatocellular carcinoma: a controlled study]
    O Seror
    Service de Radiologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Avenue du 14 Juillet, 93140 Bondy
    J Radiol 88:1157-64. 2007
    ..To evaluate the risk of radiofrequency ablation treatment failure for hepatocellular carcinomas (HCC) next to large vessels...
  18. doi request reprint Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C
    M Sasso
    R and D Department, Echosens, Paris, France
    J Viral Hepat 19:244-53. 2012
    ..CAP is a novel tool to assess the degree of steatosis and both fibrosis and steatosis can be evaluated noninvasively during the same procedure using Fibroscan(®) , in patients with CHC...
  19. ncbi request reprint Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study
    N Bonilla
    Cochin Institute, U567 INSERM, UMR8104 CNRS, Paris 5 University, Paris, France
    J Viral Hepat 13:474-81. 2006
    ....
  20. doi request reprint Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis
    M Lemoine
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Aliment Pharmacol Ther 28:1102-10. 2008
    ..Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT). Liver stiffness measurement (LSM) is a non-invasive method for liver fibrosis assessment...
  21. ncbi request reprint Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions
    C Christidis
    Department of Hepatogastroenterology, Jean Verdier Hospital, Bondy, France
    J Hepatol 35:726-32. 2001
    ..The basis of these adverse effects is the lysosomal storage of HES in Kupffer cells and hepatocytes...
  22. ncbi request reprint Evolution of previous sarcoidosis under type 1 interferons given for severe associated disease
    C Charlier
    Service de Pneumologie, Avicenne Univeristy Hospital, Assistance Publique Hopitaux de Paris, 93009 Bobigny, France
    Eur Respir J 25:570-3. 2005
    ..However, their effect in persistent forms of the disease needs further evaluation...
  23. ncbi request reprint Review article: intra-arterial treatments in patients with hepatocellular carcinoma
    J C Trinchet
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance publique hôpitaux de Paris et UFR SMBH université Paris XIII, Bondy, France
    Aliment Pharmacol Ther 17:111-8. 2003
    ..The effects of radioactive iodine either in the treatment of advanced cases or the prevention of recurrences after a curative treatment must be investigated further...
  24. ncbi request reprint [Should we screen for hepatocellular carcinoma?]
    Jean Claude Trinchet
    Hépato Gastroentérologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, UFR SMBH Université Paris 13, 93143 Bondy Cedex
    Gastroenterol Clin Biol 30:880-6. 2006
  25. ncbi request reprint [Practical screening and early treatment of hepatocellular carcinoma. Results of a French survey]
    Nathalie Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier AP HP, Universite Paris 13, Bondy 93140, France
    Gastroenterol Clin Biol 26:570-7. 2002
    ..To describe French practices for screening hepatocellular carcinoma...
  26. pmc Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis
    Pierre Nahon
    Department of Hepatology, Jean Verdier Hospital AP HP, Service d Hepatologie Hospital Jean Verdier Avenue du 14 Juillet, Bondy 93140, France
    World J Gastroenterol 14:713-9. 2008
    ....
  27. ncbi request reprint Manganese superoxide dismutase dimorphism and iron overload, hepatocellular carcinoma, and death in hepatitis C virus-infected patients
    Pierre Nahon
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy, France
    Clin Gastroenterol Hepatol 5:630-5. 2007
    ..The aim of this study was to assess the influence of the Ala-9Val MnSOD dimorphism on the same parameters and events in hepatitis C virus (HCV)-infected patients...
  28. ncbi request reprint Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study
    Pierre Nahon
    UPRES EA 3410, UFR SMBH, Paris 13 University, Bobigny, France
    Eur J Gastroenterol Hepatol 19:425-31. 2007
    ..Their influence on the prognosis of alcoholic liver disease is unknown...
  29. ncbi request reprint [Percutaneous ablation of hepatocellular carcinoma]
    Véronique Sitruk
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP et UFR SMBH
    Gastroenterol Clin Biol 27:381-90. 2003
  30. ncbi request reprint Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis
    Gisèle N'kontchou
    Department of Hepatogastroenterology, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, UPRES EA 3409, UFR SMBH, Universite Paris 13, Bondy, France
    Clin Gastroenterol Hepatol 4:1062-8. 2006
    ..The aim of this study was to show the predictive value of these factors in a cohort of 771 patients with well-compensated alcohol- or hepatitis C (HCV)-related cirrhosis who were screened prospectively for HCC...
  31. ncbi request reprint Interventional radiology as a fine art
    Michel Beaugrand
    J Hepatol 46:362-4. 2007
  32. ncbi request reprint [Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis]
    Nathalie Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP et UFR SMBH, Universite Paris 13, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 26:73-7. 2002
  33. ncbi request reprint Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis
    Angela Sutton
    UPRES 3410, UFR Santé, Médecine et Biologie Humaine, Universite Paris XIII, Bobigny, France
    Cancer Res 66:2844-52. 2006
    ..0002; relative risk, 3.40). In conclusion, polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in French alcoholic patients with cirrhosis...
  34. ncbi request reprint Local/regional and systemic treatments of hepatocellular carcinoma
    Michel Beaugrand
    Liver Unit, Hopital Jean Verdier, 93143 Bondy, France
    Semin Liver Dis 25:201-11. 2005
    ....
  35. ncbi request reprint Radiofrequency ablation for the treatment of liver tumors in the caudate lobe
    Olivier Seror
    Department of Radiology, Centre Hospitalier Universitaire Jean Verdier and UPRES EA 3409, UFR SMBH, Paris XIII, France
    J Vasc Interv Radiol 16:981-90. 2005
    ..To evaluate the effectiveness of radiofrequency (RF) ablation for liver tumors located in the caudate lobe...
  36. ncbi request reprint [Non-surgical treatment of hepatocellular carcinoma. An overview]
    Michel Beaugrand
    Service d Hepatogastroenterologie, Hopital Jean Verdier, Assistance publique hôpitaux de Paris et UFR SMBH université Paris XIII, 93143 Bondy Cedex, France
    Cancer Radiother 9:464-9. 2005
    ..Its antitumoral effect mainly due to ischemia is well documented but the influence on survival remains controversial. Finally systemic treatments have yet to be demonstrated useful: new agents and new randomised trials are still needed...
  37. ncbi request reprint [Comments on case report: A 2.5 cm liver nodule discovered at ultrasound in a patient with controlled hepatitis C]
    Véronique Sitruk
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP et UFR SMBH, Universite Paris 13, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 26:78-80. 2002
  38. ncbi request reprint [Natural history of HCV infection]
    Jean Claude Trinchet
    Service d Hepato Gastroenterologie, Hôpital Jean Verdier AP HP et UFR SMBH Université Paris 13, Bondy
    Gastroenterol Clin Biol 26:B144-53. 2002
  39. ncbi request reprint Systemic treatment of hepatocellular carcinoma
    Nathalie Ganne-Carrie
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, UPRES EA 3904, UFR SMBH, Universite Paris, Bondy, France
    Eur J Gastroenterol Hepatol 16:275-81. 2004
    ..Some of these drugs are currently being tested in preliminary studies or even large randomized trials...
  40. ncbi request reprint [Hepatitis C virus screening in drug users in an addiction out-patient unit]
    Veronique Grando-Lemaire
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, 93143 Bondy Cedex, France
    Gastroenterol Clin Biol 26:1091-6. 2002
    ..To investigate the feasibility and efficacy of hepatitis C virus screening in drug users in an addiction out-patient unit...
  41. ncbi request reprint Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis
    Pierre Nahon
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique Hopitaux de Paris, Bondy, France
    Gastroenterology 134:102-10. 2008
    ..The aim of this work was to clarify this influence in a large cohort of prospectively followed-up cirrhotic patients classified according to the cause of their liver disease...
  42. ncbi request reprint Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis
    Pierre Nahon
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Assistance Publique, Hopitaux de Paris, Bondy, France
    Gastroenterol Clin Biol 29:347-52. 2005
    ..We studied the prognostic value of hepatic venous pressure gradient in addition to epidemiological and clinical parameters in these patients...
  43. ncbi request reprint Guidelines for the diagnosis of uncomplicated cirrhosis
    Helene Fontaine
    Unité d Hépatologie Médicale, Hopital Cochin, Paris, France
    Gastroenterol Clin Biol 31:504-9. 2007
  44. ncbi request reprint Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients
    Gisèle N'kontchou
    Department of Hepato Gastroenterology, Hopital Jean Verdier, Bondy Cedex, France
    Eur J Gastroenterol Hepatol 17:179-84. 2005
    ..We provide a retrospective review of results and the tolerance of all PSE procedures in patients with cirrhosis in our department...
  45. ncbi request reprint Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
    Marianne Ziol
    UPRES EA 3406, University of Paris 13, Bobigny, France
    Hepatology 41:48-54. 2005
    ..In conclusion, noninvasive assessment of liver stiffness with transient elastography appears as a reliable tool to detect significant fibrosis or cirrhosis in patients with chronic hepatitis C...
  46. ncbi request reprint Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death
    Pierre Nahon
    Service d Hepatologie, Hopital Jean Verdier, AP HP, Bondy, France
    Clin Gastroenterol Hepatol 3:292-8. 2005
    ....
  47. ncbi request reprint [Predictive factors for progression to cirrhosis in chronic liver diseases]
    Veronique Grando-Lemaire
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, Universite Paris 13, 93143 Bondy Cedex
    Rev Prat 55:1533-5, 1537-8. 2005
    ..The control of liver damage aetiologies could decrease or even stop fibrosis progression...
  48. ncbi request reprint Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France)
    Nathalie Ganne-Carrie
    Service d Hepato Gastroenterologie, Hôpital Jean Verdier Bondy, Assistance Publique Hopitaux de Paris, UPRES 3409, UFR Santé Médecine Biologie Humaine, Universite Paris 13, France
    J Med Virol 78:335-40. 2006
    ..002). It is concluded that HBV genotypes A, B, C, D, and E circulate in the Seine Saint Denis District, reflecting the geographical origin of patients. HBV/A, /C and/D seem to be associated with more severe hepatic disease...
  49. ncbi request reprint Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
    Farhad Kazemi
    Hepatology Department, Hopital Jean Verdier, APHP, Universite Paris 13, Bondy, France
    J Hepatol 45:230-5. 2006
    ..Periodic endoscopic screening for oesophageal varices is recommended in patients with cirrhosis, but might be limited to a subgroup of patients if a simple non-invasive test was available to select those at risk of bleeding...
  50. ncbi request reprint Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases
    Nathalie Ganne-Carrie
    Hépato Gastroentérologie, Hopital Jean Verdier, Bondy, France UPRES EA3409, Universite Paris 13, Bobigny, France
    Hepatology 44:1511-7. 2006
    ..6 kPa. False-negatives are mainly attributable to inactive or macronodular cirrhosis...
  51. ncbi request reprint Hepatocellular carcinoma (primary cancer of the liver)
    Jean Claude Barbare
    Institut National du Cancer, Boulogne Billancourt
    Gastroenterol Clin Biol 30:2S57-2S61. 2006
  52. ncbi request reprint Liver stiffness measurement versus clinicians' prediction or both for the assessment of liver fibrosis in patients with chronic hepatitis C
    Pierre Nahon
    Service d Hepato Gastroenterologie, Hopital Jean Verdier, AP HP, Bondy, France
    Am J Gastroenterol 101:2744-51. 2006
    ..The goal of this study was to estimate the additional value of liver stiffness measurement (LSM) with physicians' assessment of fibrosis based on epidemiological, clinical, and biological parameters...
  53. ncbi request reprint [Diagnosis of cirrhosis]
    Jean Claude Trinchet
    Gastroenterol Clin Biol 28:D121-8. 2004
  54. ncbi request reprint [Why and how to evaluate liver fibrosis in 2007]
    Jean Claude Trinchet
    Gastroenterol Clin Biol 31:501-3. 2007
  55. ncbi request reprint Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin
    Roland El Braks
    Department of Hepatology, Hopital Jean Verdier, Bondy 93140, France
    World J Gastroenterol 13:5648-53. 2007
    ..To assess the long-term clinical benefit of sustained virological response (SVR) in patients with hepatitis C virus (HCV) cirrhosis treated by antiviral therapy using mostly ribavirin plus interferon either standard or pegylated...